These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11102942)

  • 1. Lack of sex-ratio distortion in neurofibromatosis 2.
    Baser ME; Evans DG
    Am J Med Genet; 2000 Nov; 95(3):292. PubMed ID: 11102942
    [No Abstract]   [Full Text] [Related]  

  • 2. Consanguinity and disease coincidence.
    Buchan JC; Bradbury JA; Sheridan E
    Eye (Lond); 2003 Mar; 17(2):280-2. PubMed ID: 12640435
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular dysplasia in neurofibromatosis type 2.
    Ryan AM; Hurley M; Brennan P; Moroney JT
    Neurology; 2005 Jul; 65(1):163-4. PubMed ID: 16009910
    [No Abstract]   [Full Text] [Related]  

  • 4. [Meningiomas: prognostic relevance of histopathologic and genetic markers].
    Kros JM; Wolbers JG
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2160-5. PubMed ID: 11727613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial meningiomas and neurofibromatosis type 2.
    Gokce G; Ceylan OM; Mutlu FM; Altinsoy HI
    Acta Neurochir (Wien); 2014 Jun; 156(6):1103. PubMed ID: 24652317
    [No Abstract]   [Full Text] [Related]  

  • 6. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vascular disease in neurofibromatosis type 2: association or coincidence?
    Cordeiro NJ; Gardner KR; Huson SM; Stewart H; Elston JS; Howard EL; Tullus KO; Pike MG
    Dev Med Child Neurol; 2006 Jan; 48(1):58-9. PubMed ID: 16359595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma.
    Martínez-Glez V; Franco-Hernández C; Lomas J; Peña-Granero C; de Campos JM; Isla A; Rey JA
    Cancer Genet Cytogenet; 2007 Mar; 173(2):170-2. PubMed ID: 17321335
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed tumour of schwannoma and meningioma in a patient with neurofibromatosis-2 : a case report.
    Elizabeth J; Menon G; Nair S; Radhakrishnan VV
    Neurol India; 2001 Dec; 49(4):398-400. PubMed ID: 11799416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis 2, radiosurgery and malignant nervous system tumours.
    Baser ME; Evans DG; Jackler RK; Sujansky E; Rubenstein A
    Br J Cancer; 2000 Feb; 82(4):998. PubMed ID: 10732777
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke in a child with neurofibromatosis type 2.
    Ng J; Mordekar SR; Connolly DJ; Baxter P
    Eur J Paediatr Neurol; 2009 Jan; 13(1):77-9. PubMed ID: 18406647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring.
    Moyhuddin A; Baser ME; Watson C; Purcell S; Ramsden RT; Heiberg A; Wallace AJ; Evans DG
    J Med Genet; 2003 Jun; 40(6):459-63. PubMed ID: 12807969
    [No Abstract]   [Full Text] [Related]  

  • 15. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.
    Baser ME;
    Hum Mutat; 2006 Apr; 27(4):297-306. PubMed ID: 16521120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Genotypes and risk of glioma and meningioma.
    Malmer B; Feychting M; Lönn S; Ahlbom A; Henriksson R
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2220-3. PubMed ID: 16172235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 2-living with the complications: a case study.
    Harris C
    J Neurosci Nurs; 2005 Jun; 37(3):156-8. PubMed ID: 16001821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and mortality of neurofibromatosis: a total population study in Finland.
    Uusitalo E; Leppävirta J; Koffert A; Suominen S; Vahtera J; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
    J Invest Dermatol; 2015 Mar; 135(3):904-906. PubMed ID: 25354145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.